Lysophosphatidic acid synthesis and release

Prostaglandins & Other Lipid Mediators
C PagèsJ S Saulnier-Blache

Abstract

Lysophosphatidic acid (LPA) is a bioactive phospholipid controlling numerous cellular responses through the activation of specific G-protein coupled transmembrane receptors. LPA is present in several biological fluids (serum, plasma, aqueous humor) and can be secreted by several cell types (platelets, fibroblasts, adipocytes, cancer cells). Whereas, multiple pathways of synthesis and degradation of LPA have been described, their relative contribution in extracellular secretion and biodisponibility is still a matter of debate. The first part of the present review is devoted to the description of the different enzymes involved in LPA synthesis (acyltransferases, phospholipases, kinases) and degradation (lysophospholipases, lipid-phosphatases), as well as to the molecules involved in LPA transport (albumin, fatty acid binding proteins, gelsolin, lipoproteins). In a second part, the different physio-pathological situations (aggregation, cancer, injuries) associated with LPA production, as well as the potential role played by LPA in genesis of certain diseases (cancer, obesity, arteriosclerosis) are listed and analyzed.

References

Jan 1, 1992·Methods in Enzymology·D Haldar, A Vancura
Apr 8, 1992·Biochimica Et Biophysica Acta·R L van der BendW J van Blitterswijk
Jan 3, 1986·Biochimica Et Biophysica Acta·A TokumuraH Tsukatani
Oct 30, 1985·Biochemical and Biophysical Research Communications·M E Dunlop, R G Larkins
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·H N Higgs, J A Glomset
Jun 1, 1994·The Biochemical Journal·F J Thompson, M A Clark
Jul 1, 1994·The American Journal of Physiology·A TokumuraS Tanaka
Aug 1, 1994·The Biochemical Journal·A E ThumserD C Wilton
May 1, 1993·The Biochemical Journal·T EichholtzW H Moolenaar
May 24, 1996·Chemistry and Physics of Lipids·D N Brindley, D W Waggoner
Mar 28, 1997·The Journal of Biological Chemistry·J TangS S Jones
May 12, 1998·The American Journal of Physiology·K LiliomM A Watsky
Jun 24, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M WestermannS Rodenhuis
Sep 5, 1998·JAMA : the Journal of the American Medical Association·Y XuG Casey
Feb 27, 1999·Current Opinion in Cell Biology·D J Kwiatkowski
Apr 10, 1999·Journal of Nutritional Science and Vitaminology·T SasagawaM Okita
Jul 9, 1999·Biochimica Et Biophysica Acta·A Wang, E A Dennis
Aug 14, 1999·Biochimica Et Biophysica Acta·E M BeversR F Zwaal
Apr 1, 1963·Biochemical Pharmacology·W VOGT

❮ Previous
Next ❯

Citations

May 28, 2008·Angiogenesis·Carol M Rivera-LopezKevin R Lynch
Jun 27, 2003·Trends in Endocrinology and Metabolism : TEM·Anil K Agarwal, Abhimanyu Garg
Jun 19, 2002·Biochimica Et Biophysica Acta·Marion R SteinerSheldon M Steiner
Jun 19, 2002·Biochimica Et Biophysica Acta·Tracee Scalise Panetti
Jun 19, 2002·Biochimica Et Biophysica Acta·Xianjun FangGordon B Mills
Jun 19, 2002·Biochimica Et Biophysica Acta·Yuhuan XieKathryn E Meier
Oct 16, 2007·Expert Reviews in Molecular Medicine·Mandi Murph, Gordon B Mills
Aug 31, 2002·Journal of Hematotherapy & Stem Cell Research·Yuri Y SautinStanislav I Svetlov
May 12, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Ji Heon RhimSang Chul Park
Jun 22, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Andreas C ErikssonUlrika K Nilsson
Jun 11, 2004·Annual Review of Biochemistry·Isao IshiiJerold Chun
Dec 10, 2002·Annual Review of Physiology·Nick Osborne, Didier Y R Stainier
Nov 29, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ponugoti Vasantha Rao
Jun 16, 2014·The Journal of Evidence-based Dental Practice·Casey Hein, Eraldo L Batista
Mar 26, 2011·Expert Opinion on Investigational Drugs·Chloé RancouleJean-Sébastien Saulnier-Blache
Feb 20, 2015·Neuron·Yun C YungJerold Chun
Oct 20, 2009·Trends in Endocrinology and Metabolism : TEM·Xiaoqin Ye, Jerold Chun
Oct 2, 2015·Biological & Pharmaceutical Bulletin·Byung-Hwan LeeSeung-Yeol Nah
Mar 25, 2010·Prostaglandins & Other Lipid Mediators·Mu-En LinJerold Chun
Aug 25, 2005·The Journal of Investigative Dermatology·Juliette Mazereeuw-HautierJean-Sébastien Saulnier-Blache
Nov 10, 2007·Prostaglandins & Other Lipid Mediators·Alice PébayStuart M Pitson
Nov 5, 2004·Diabetes & Metabolism·V LargeM Beylot
Dec 6, 2006·Seminars in Cell & Developmental Biology·P Vasantha Rao, Rupalatha Maddala
Feb 19, 2013·Journal of Tissue Engineering and Regenerative Medicine·Stéphane ChabaudStéphane Bolduc
Jul 20, 2004·Journal of Cellular Biochemistry·Julie D Saba
Feb 9, 2011·Journal of Cellular Physiology·Jong Hyun Kim, Robert S Adelstein
Aug 16, 2011·British Journal of Pharmacology·Tetsuji MutohJerold Chun
Oct 4, 2011·International Journal of Cancer. Journal International Du Cancer·Ruey-Jien ChenMing-Chieh Lin
Jul 24, 2004·Seminars in Cell & Developmental Biology·Brigitte Anliker, Jerold Chun
Jul 24, 2004·Seminars in Cell & Developmental Biology·Susan PynePeter I Darroch
May 27, 2006·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Elizabeth BarekziJohn W Steinke
Jan 13, 2006·Trends in Molecular Medicine·Shannon E GardellJerold Chun
May 1, 2010·The American Journal of Pathology·Martine BotErik A L Biessen
Oct 6, 2012·Biochimica Et Biophysica Acta·Jing ShiXuemin Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.